Details and Download Full Text PDF:
Psoriasiform eruption triggered by a dipeptidyl peptidase IV inhibitor.
Australas J Dermatol 2012 Feb 13;53(1):70-2. Epub 2011 Jun 13.
Department of Dermatology, University Hospital of Asturias, Oviedo, Spain.
Psoriatic patients have a higher prevalence of diabetes mellitus type 2 (DM). Since dipeptidyl peptidase IV (DPP-IV) dysregulation is present in DM and psoriasis, DPP-IV inhibitors have been proposed as therapeutic agents for both conditions. We report a psoriasiform eruption induced by sitagliptin, a DPP-IV inhibitor. The role of DPP-IV in the pathogenesis of DM is well established; however data on psoriatic patients is contradictory. More studies are required to elucidate the effect of DPP-IV inhibitors and their relationship with DM and psoriasis.
|PDF Download - Full Text Link
( Please be advised that this article is hosted on an external website not affiliated with PubFacts.com)